The Food and Drug Administration (FDA) has recently approved a blood test that can assist in the primary detection of colorectal cancer. This test could assist with prompt detection and intervention ...

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t cancel your colonoscopy just yet — that old standby is still more reliable ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, demonstrating high sensitivity for both malignant and advanced precancerous lesions ...

Please provide your email address to receive an email when new articles are posted on . A blood-based test demonstrated high sensitivity for colorectal cancer among individuals with average risk. The ...

For the first time, the U.S. Food and Drug Administration has approved a blood test as a primary screening option for colorectal cancer. Guardant Health's Shield blood test was approved Monday as a ...

Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer that may remain in the body after treatment and can signal a higher risk of ...

Colorectal cancer is one of the leading causes of cancer deaths worldwide. Until now, colonoscopy has been the most reliable test, but many people avoid it because it is invasive, expensive, and ...

Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated ...

Share on Pinterest Scientists are working on a new test to predict colorectal cancer in IBD patients. South_agency/Getty Images People with inflammatory bowel disease (IBD) are at an increased risk of ...

A new blood test that screens for colorectal cancer has just been approved by the Food and Drug Administration (FDA). The blood sample needed for the new test, called Shield, can be obtained at a ...